Clinical and genetic risk factors for Fulvestrant treatment in post-menopause ER-positive advanced breast cancer patients

by Jingyu Liu, Jing Li, Hui Wang, Yikai Wang, Qiongzhi He, Xuefeng Xia, Zhe-Yu Hu, Quchang Ouyang
Published 2019-01-01

Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer

by Dabo Zhou, Quchang Ouyang, Liping Liu, Jingyu Liu, Yu Tang, Mengjia Xiao, Yikai Wang, Qiongzhi He, Zhe-Yu Hu
Published 2019-05-01

Corrigendum to “Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer” [Translational Oncology (2019) 12, 764–774]

by Dabo Zhou, Liping Liu, Jingyu Liu, Yu Tang, Mengjia Xiao, Yikai Wang, Qiongzhi He, Zhe-Yu Hu, Quchang Ouyang
Published 2021-12-01

Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance

by Zhe-Yu Hu, Ning Xie, Can Tian, Xiaohong Yang, Liping Liu, Jing Li, Huawu Xiao, Hui Wu, Jun Lu, Jianxiang Gao, Xuming Hu, Min Cao, Zhengrong Shui, Mengjia Xiao, Yu Tang, Qiongzhi He, Lianpeng Chang, Xuefeng Xia, Xin Yi, Qianjin Liao, Quchang Ouyang
Published 2018-06-01

Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer

by Qiang Wang, Qiang Wang, Danting Zhou, Danting Zhou, Fang Wu, Qingchun Liang, Qiongzhi He, Muyun Peng, Muyun Peng, Tianyu Yao, Tianyu Yao, Yan Hu, Yan Hu, Banglun Qian, Banglun Qian, Jingqun Tang, Jingqun Tang, Xiang Wang, Xiang Wang, Wenliang Liu, Wenliang Liu, Fenglei Yu, Fenglei Yu, Chen Chen, Chen Chen
Published 2021-07-01